While Drug Sector Suffers From Price Cuts, Medical Devices Steal The Show - Device China Conference
This article was originally published in PharmAsia News
Executive Summary
SUZHOU, China - China's government is increasing medical expenditure dramatically to support its healthcare reforms and to ensure all citizens are covered by medical insurance by 2020
You may also be interested in...
With Latest Round Of Cuts, China Continues March To Narrow Gap Between Big Pharma And Local Generics
SHANGHAI - As expected, China's powerful National Development and Reform Commission announced Aug. 5 a new round of price cuts, this time targeting hormone and endocrinology drugs and central nervous system drugs, with an average cut of roughly 14%, according to analysts
China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
Medtronic Launches New Facilities In Shanghai And Singapore; Thermo Fisher To Open Fifth China Plant
Medtronic Inc. raised its Asian profile last week with opening ceremonies for a regional headquarters building in Shanghai and a manufacturing plant in Singapore. The company plans to add 1,000 skilled staff to its China workforce in the next five years